A Phase 1, Open Label, Two-cohort, Single-Sequence, Crossover Study to Investigate the Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers
Latest Information Update: 16 Jan 2020
At a glance
- Drugs Amlodipine/rosuvastatin/telmisartan (Primary) ; Amlodipine/telmisartan (Primary) ; Rosuvastatin (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Yuhan
- 31 Jan 2017 Status changed from active, no longer recruiting to completed.
- 05 Nov 2016 New trial record